Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.620
+0.060 (1.32%)
Jun 27, 2025, 4:00 PM - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $316.11 million as of June 27, 2025. Its market cap has decreased by -51.91% in one year.
Market Cap
316.11M
Enterprise Value
-75.45M
1-Year Change
-51.91%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $316.11M, a decrease of -82.39%. That is a compound annual growth rate of -31.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 280.53M | -34.77% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |